cmcmaster/rheumatology_pbs_schedule · Datasets at Hugging Face

pbs_code stringlengths 5 6	drug stringclasses 15 values	brand stringclasses 29 values	formulation stringclasses 35 values	indication stringclasses 7 values	treatment_phase stringclasses 53 values	streamlined_code stringclasses 33 values	online_application bool 2 classes	authority_method stringclasses 2 values	hospital_type stringclasses 3 values	schedule_code int64 4.03k 4.03k	schedule_year int64 2.02k 2.02k	schedule_month stringclasses 1 value
13308K	etanercept	Enbrel	Injections 50 mg in 1 mL single use pre-filled syringes, 4	juvenile idiopathic arthritis	Continuing treatment	14154	true	STREAMLINED	Public	4,030	2,024	AUGUST
13757C	tofacitinib	Xeljanz	Tablet 5 mg	juvenile idiopathic arthritis	Transitioning from non-PBS to PBS-subsidised supply - Grandfather arrangements	null	true	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST
9034L	adalimumab	Abrilada	Injection 40 mg in 0.8 mL pre-filled syringe	psoriatic arthritis	Continuing treatment - balance of supply	null	true	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST
9034L	adalimumab	Idacio	Injection 40 mg in 0.8 mL pre-filled syringe	psoriatic arthritis	Continuing treatment - balance of supply	null	true	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST
9034L	adalimumab	Hadlima	Injection 40 mg in 0.8 mL pre-filled syringe	psoriatic arthritis	Continuing treatment - balance of supply	null	true	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST
9034L	adalimumab	Hyrimoz	Injection 40 mg in 0.8 mL pre-filled syringe	psoriatic arthritis	Continuing treatment - balance of supply	null	true	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST
9034L	adalimumab	Amgevita	Injection 40 mg in 0.8 mL pre-filled syringe	psoriatic arthritis	Continuing treatment - balance of supply	null	true	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST
9034L	adalimumab	Abrilada	Injection 40 mg in 0.8 mL pre-filled syringe	psoriatic arthritis	First continuing treatment	null	false	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST
9034L	adalimumab	Idacio	Injection 40 mg in 0.8 mL pre-filled syringe	psoriatic arthritis	First continuing treatment	null	false	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST
9034L	adalimumab	Hadlima	Injection 40 mg in 0.8 mL pre-filled syringe	psoriatic arthritis	First continuing treatment	null	false	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST
9034L	adalimumab	Hyrimoz	Injection 40 mg in 0.8 mL pre-filled syringe	psoriatic arthritis	First continuing treatment	null	false	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST
9034L	adalimumab	Amgevita	Injection 40 mg in 0.8 mL pre-filled syringe	psoriatic arthritis	First continuing treatment	null	false	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST
9034L	adalimumab	Abrilada	Injection 40 mg in 0.8 mL pre-filled syringe	psoriatic arthritis	Subsequent continuing treatment	null	false	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST
9034L	adalimumab	Idacio	Injection 40 mg in 0.8 mL pre-filled syringe	psoriatic arthritis	Subsequent continuing treatment	null	false	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST
9034L	adalimumab	Hadlima	Injection 40 mg in 0.8 mL pre-filled syringe	psoriatic arthritis	Subsequent continuing treatment	null	false	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST
9034L	adalimumab	Hyrimoz	Injection 40 mg in 0.8 mL pre-filled syringe	psoriatic arthritis	Subsequent continuing treatment	null	false	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST
9034L	adalimumab	Amgevita	Injection 40 mg in 0.8 mL pre-filled syringe	psoriatic arthritis	Subsequent continuing treatment	null	false	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST
11516D	golimumab	Simponi	Injection 50 mg in 0.5 mL single use pre-filled syringe	non-radiographic axial spondyloarthritis	Continuing treatment - balance of supply	null	true	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST
11516D	golimumab	Simponi	Injection 50 mg in 0.5 mL single use pre-filled syringe	non-radiographic axial spondyloarthritis	Continuing treatment	null	true	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST
10767Q	ustekinumab	Stelara	Injection 45 mg in 0.5 mL	psoriatic arthritis	Continuing treatment - balance of supply	null	true	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST
10767Q	ustekinumab	Stelara	Injection 45 mg in 0.5 mL	psoriatic arthritis	Continuing treatment	null	false	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST
13720D	tocilizumab	Actemra ACTPen	Injection 162 mg in 0.9 mL single use pre-filled pen	rheumatoid arthritis	Subsequent continuing treatment	14499	true	STREAMLINED	Any	4,030	2,024	AUGUST
13065P	infliximab	Remsima SC	Solution for injection 120 mg in 1 mL pre-filled syringe	ankylosing spondylitis	Balance of supply (including switching formulation) where the full duration of treatment available under a particular treatment phase was not requested in the preceding prescription	null	true	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST
12217B	ixekizumab	Taltz	Injection 80 mg in 1 mL single dose pre-filled pen	ankylosing spondylitis	Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)	null	false	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST
12217B	ixekizumab	Taltz	Injection 80 mg in 1 mL single dose pre-filled pen	ankylosing spondylitis	Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years)	null	false	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST
12217B	ixekizumab	Taltz	Injection 80 mg in 1 mL single dose pre-filled pen	ankylosing spondylitis	Initial treatment - Initial 1 (new patient), Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply	null	true	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST
12217B	ixekizumab	Taltz	Injection 80 mg in 1 mL single dose pre-filled pen	ankylosing spondylitis	Initial treatment - Initial 1 (new patient)	null	false	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST
3428K	golimumab	Simponi	Injection 50 mg in 0.5 mL single use pre-filled syringe	rheumatoid arthritis	First continuing treatment	null	false	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST
3428K	golimumab	Simponi	Injection 50 mg in 0.5 mL single use pre-filled syringe	rheumatoid arthritis	First continuing treatment - balance of supply	null	true	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST
11375Q	golimumab	Simponi	Injection 50 mg in 0.5 mL single use pre-filled pen	rheumatoid arthritis	First continuing treatment - balance of supply	null	true	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST
11375Q	golimumab	Simponi	Injection 50 mg in 0.5 mL single use pre-filled pen	rheumatoid arthritis	First continuing treatment	null	false	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST
3449M	etanercept	Enbrel	Injections 50 mg in 1 mL single use pre-filled syringes, 4	juvenile idiopathic arthritis	Continuing Treatment - balance of supply	null	true	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST
3449M	etanercept	Enbrel	Injections 50 mg in 1 mL single use pre-filled syringes, 4	juvenile idiopathic arthritis	Continuing treatment	null	false	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST
13223Y	adalimumab	Yuflyma	Injection 40 mg in 0.4 mL pre-filled pen	juvenile idiopathic arthritis	Subsequent continuing treatment	11604	true	STREAMLINED	Any	4,030	2,024	AUGUST
13223Y	adalimumab	Adalicip	Injection 40 mg in 0.4 mL pre-filled pen	juvenile idiopathic arthritis	Subsequent continuing treatment	11604	true	STREAMLINED	Any	4,030	2,024	AUGUST
11498E	infliximab	Inflectra	Powder for I.V. infusion 100 mg	psoriatic arthritis	Subsequent continuing treatment	null	false	AUTHORITY_REQUIRED	Private	4,030	2,024	AUGUST
11498E	infliximab	Renflexis	Powder for I.V. infusion 100 mg	psoriatic arthritis	Subsequent continuing treatment	null	false	AUTHORITY_REQUIRED	Private	4,030	2,024	AUGUST
11498E	infliximab	Remicade	Powder for I.V. infusion 100 mg	psoriatic arthritis	Subsequent continuing treatment	null	false	AUTHORITY_REQUIRED	Private	4,030	2,024	AUGUST
11197H	etanercept	Enbrel	Injection set containing 4 vials powder for injection 25 mg and 4 pre-filled syringes solvent 1 mL	rheumatoid arthritis	Subsequent continuing treatment	14499	true	STREAMLINED	Any	4,030	2,024	AUGUST
6448J	infliximab	Remicade	Powder for I.V. infusion 100 mg	ankylosing spondylitis	Initial treatment - Initial 1 (new patient), Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply	null	true	AUTHORITY_REQUIRED	Private	4,030	2,024	AUGUST
6448J	infliximab	Inflectra	Powder for I.V. infusion 100 mg	ankylosing spondylitis	Initial treatment - Initial 1 (new patient), Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply	null	true	AUTHORITY_REQUIRED	Private	4,030	2,024	AUGUST
6448J	infliximab	Renflexis	Powder for I.V. infusion 100 mg	ankylosing spondylitis	Initial treatment - Initial 1 (new patient), Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply	null	true	AUTHORITY_REQUIRED	Private	4,030	2,024	AUGUST
6448J	infliximab	Remicade	Powder for I.V. infusion 100 mg	ankylosing spondylitis	Initial treatment - Initial 1 (new patient)	null	false	AUTHORITY_REQUIRED	Private	4,030	2,024	AUGUST
6448J	infliximab	Inflectra	Powder for I.V. infusion 100 mg	ankylosing spondylitis	Initial treatment - Initial 1 (new patient)	null	false	AUTHORITY_REQUIRED	Private	4,030	2,024	AUGUST
6448J	infliximab	Renflexis	Powder for I.V. infusion 100 mg	ankylosing spondylitis	Initial treatment - Initial 1 (new patient)	null	false	AUTHORITY_REQUIRED	Private	4,030	2,024	AUGUST
6448J	infliximab	Remicade	Powder for I.V. infusion 100 mg	ankylosing spondylitis	Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)	null	false	AUTHORITY_REQUIRED	Private	4,030	2,024	AUGUST
6448J	infliximab	Inflectra	Powder for I.V. infusion 100 mg	ankylosing spondylitis	Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)	null	false	AUTHORITY_REQUIRED	Private	4,030	2,024	AUGUST
6448J	infliximab	Renflexis	Powder for I.V. infusion 100 mg	ankylosing spondylitis	Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)	null	false	AUTHORITY_REQUIRED	Private	4,030	2,024	AUGUST
6448J	infliximab	Remicade	Powder for I.V. infusion 100 mg	ankylosing spondylitis	Continuing treatment - balance of supply	null	true	AUTHORITY_REQUIRED	Private	4,030	2,024	AUGUST
6448J	infliximab	Inflectra	Powder for I.V. infusion 100 mg	ankylosing spondylitis	Continuing treatment - balance of supply	null	true	AUTHORITY_REQUIRED	Private	4,030	2,024	AUGUST
6448J	infliximab	Renflexis	Powder for I.V. infusion 100 mg	ankylosing spondylitis	Continuing treatment - balance of supply	null	true	AUTHORITY_REQUIRED	Private	4,030	2,024	AUGUST
6448J	infliximab	Remicade	Powder for I.V. infusion 100 mg	ankylosing spondylitis	Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years)	null	false	AUTHORITY_REQUIRED	Private	4,030	2,024	AUGUST
6448J	infliximab	Inflectra	Powder for I.V. infusion 100 mg	ankylosing spondylitis	Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years)	null	false	AUTHORITY_REQUIRED	Private	4,030	2,024	AUGUST
6448J	infliximab	Renflexis	Powder for I.V. infusion 100 mg	ankylosing spondylitis	Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years)	null	false	AUTHORITY_REQUIRED	Private	4,030	2,024	AUGUST
6448J	infliximab	Remicade	Powder for I.V. infusion 100 mg	ankylosing spondylitis	First continuing treatment	null	false	AUTHORITY_REQUIRED	Private	4,030	2,024	AUGUST
6448J	infliximab	Inflectra	Powder for I.V. infusion 100 mg	ankylosing spondylitis	First continuing treatment	null	false	AUTHORITY_REQUIRED	Private	4,030	2,024	AUGUST
6448J	infliximab	Renflexis	Powder for I.V. infusion 100 mg	ankylosing spondylitis	First continuing treatment	null	false	AUTHORITY_REQUIRED	Private	4,030	2,024	AUGUST
13228F	adalimumab	Humira	Injection 40 mg in 0.4 mL pre-filled syringe	juvenile idiopathic arthritis	Continuing treatment	14136	true	STREAMLINED	Public	4,030	2,024	AUGUST
13228F	adalimumab	Yuflyma	Injection 40 mg in 0.4 mL pre-filled syringe	juvenile idiopathic arthritis	Continuing treatment	14136	true	STREAMLINED	Public	4,030	2,024	AUGUST
13228F	adalimumab	Adalicip	Injection 40 mg in 0.4 mL pre-filled syringe	juvenile idiopathic arthritis	Continuing treatment	14136	true	STREAMLINED	Public	4,030	2,024	AUGUST
13315T	tocilizumab	Actemra	Concentrate for injection 80 mg in 4 mL	juvenile idiopathic arthritis	Continuing treatment	14179	true	STREAMLINED	Private	4,030	2,024	AUGUST
13047Q	infliximab	Remsima SC	Solution for injection 120 mg in 1 mL pre-filled syringe	psoriatic arthritis	Continuing treatment with subcutaneous form or switching from intravenous form to subcutaneous form	null	true	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST
6397Q	infliximab	Remicade	Powder for I.V. infusion 100 mg	rheumatoid arthritis	Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)	null	false	AUTHORITY_REQUIRED	Private	4,030	2,024	AUGUST
6397Q	infliximab	Renflexis	Powder for I.V. infusion 100 mg	rheumatoid arthritis	Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)	null	false	AUTHORITY_REQUIRED	Private	4,030	2,024	AUGUST
6397Q	infliximab	Inflectra	Powder for I.V. infusion 100 mg	rheumatoid arthritis	Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)	null	false	AUTHORITY_REQUIRED	Private	4,030	2,024	AUGUST
6397Q	infliximab	Remicade	Powder for I.V. infusion 100 mg	rheumatoid arthritis	Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply	null	true	AUTHORITY_REQUIRED	Private	4,030	2,024	AUGUST
6397Q	infliximab	Renflexis	Powder for I.V. infusion 100 mg	rheumatoid arthritis	Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply	null	true	AUTHORITY_REQUIRED	Private	4,030	2,024	AUGUST
6397Q	infliximab	Inflectra	Powder for I.V. infusion 100 mg	rheumatoid arthritis	Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply	null	true	AUTHORITY_REQUIRED	Private	4,030	2,024	AUGUST
6397Q	infliximab	Remicade	Powder for I.V. infusion 100 mg	rheumatoid arthritis	First continuing treatment	null	false	AUTHORITY_REQUIRED	Private	4,030	2,024	AUGUST
6397Q	infliximab	Renflexis	Powder for I.V. infusion 100 mg	rheumatoid arthritis	First continuing treatment	null	false	AUTHORITY_REQUIRED	Private	4,030	2,024	AUGUST
6397Q	infliximab	Inflectra	Powder for I.V. infusion 100 mg	rheumatoid arthritis	First continuing treatment	null	false	AUTHORITY_REQUIRED	Private	4,030	2,024	AUGUST
6397Q	infliximab	Remicade	Powder for I.V. infusion 100 mg	rheumatoid arthritis	Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months)	null	false	AUTHORITY_REQUIRED	Private	4,030	2,024	AUGUST
6397Q	infliximab	Renflexis	Powder for I.V. infusion 100 mg	rheumatoid arthritis	Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months)	null	false	AUTHORITY_REQUIRED	Private	4,030	2,024	AUGUST
6397Q	infliximab	Inflectra	Powder for I.V. infusion 100 mg	rheumatoid arthritis	Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months)	null	false	AUTHORITY_REQUIRED	Private	4,030	2,024	AUGUST
6397Q	infliximab	Remicade	Powder for I.V. infusion 100 mg	rheumatoid arthritis	First continuing treatment - balance of supply	null	true	AUTHORITY_REQUIRED	Private	4,030	2,024	AUGUST
6397Q	infliximab	Renflexis	Powder for I.V. infusion 100 mg	rheumatoid arthritis	First continuing treatment - balance of supply	null	true	AUTHORITY_REQUIRED	Private	4,030	2,024	AUGUST
6397Q	infliximab	Inflectra	Powder for I.V. infusion 100 mg	rheumatoid arthritis	First continuing treatment - balance of supply	null	true	AUTHORITY_REQUIRED	Private	4,030	2,024	AUGUST
6397Q	infliximab	Remicade	Powder for I.V. infusion 100 mg	rheumatoid arthritis	Initial treatment - Initial 1 (new patient)	null	false	AUTHORITY_REQUIRED	Private	4,030	2,024	AUGUST
6397Q	infliximab	Renflexis	Powder for I.V. infusion 100 mg	rheumatoid arthritis	Initial treatment - Initial 1 (new patient)	null	false	AUTHORITY_REQUIRED	Private	4,030	2,024	AUGUST
6397Q	infliximab	Inflectra	Powder for I.V. infusion 100 mg	rheumatoid arthritis	Initial treatment - Initial 1 (new patient)	null	false	AUTHORITY_REQUIRED	Private	4,030	2,024	AUGUST
11675L	tofacitinib	Xeljanz	Tablet 5 mg	psoriatic arthritis	Continuing treatment	null	false	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST
11675L	tofacitinib	Xeljanz	Tablet 5 mg	psoriatic arthritis	Continuing treatment - balance of supply	null	true	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST
12094M	tocilizumab	Actemra ACTPen	Injection 162 mg in 0.9 mL single use pre-filled pen	juvenile idiopathic arthritis	Balance of supply for Initial treatment - Initial 1 (new patient) or Initial 2 (retrial or recommencement of treatment after a break of less than 12 months) or Initial 3 (recommencement of treatment after a break of more than 12 months) - in a patient of any weight being administered a subcutaneous form of this biological medicine	null	true	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST
12355G	adalimumab	Abrilada	Injection 40 mg in 0.8 mL pre-filled pen	juvenile idiopathic arthritis	Continuing treatment	14136	true	STREAMLINED	Public	4,030	2,024	AUGUST
12355G	adalimumab	Amgevita	Injection 40 mg in 0.8 mL pre-filled pen	juvenile idiopathic arthritis	Continuing treatment	14136	true	STREAMLINED	Public	4,030	2,024	AUGUST
12355G	adalimumab	Hyrimoz	Injection 40 mg in 0.8 mL pre-filled pen	juvenile idiopathic arthritis	Continuing treatment	14136	true	STREAMLINED	Public	4,030	2,024	AUGUST
12355G	adalimumab	Hadlima	Injection 40 mg in 0.8 mL pre-filled pen	juvenile idiopathic arthritis	Continuing treatment	14136	true	STREAMLINED	Public	4,030	2,024	AUGUST
12355G	adalimumab	Idacio	Injection 40 mg in 0.8 mL pre-filled pen	juvenile idiopathic arthritis	Continuing treatment	14136	true	STREAMLINED	Public	4,030	2,024	AUGUST
13723G	infliximab	Inflectra	Powder for I.V. infusion 100 mg	rheumatoid arthritis	Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)	null	true	AUTHORITY_REQUIRED	Public	4,030	2,024	AUGUST
13723G	infliximab	Renflexis	Powder for I.V. infusion 100 mg	rheumatoid arthritis	Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)	null	true	AUTHORITY_REQUIRED	Public	4,030	2,024	AUGUST
13723G	infliximab	Inflectra	Powder for I.V. infusion 100 mg	rheumatoid arthritis	Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply	null	true	AUTHORITY_REQUIRED	Public	4,030	2,024	AUGUST
13723G	infliximab	Renflexis	Powder for I.V. infusion 100 mg	rheumatoid arthritis	Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply	null	true	AUTHORITY_REQUIRED	Public	4,030	2,024	AUGUST
13723G	infliximab	Inflectra	Powder for I.V. infusion 100 mg	rheumatoid arthritis	Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months)	null	true	AUTHORITY_REQUIRED	Public	4,030	2,024	AUGUST
13723G	infliximab	Renflexis	Powder for I.V. infusion 100 mg	rheumatoid arthritis	Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months)	null	true	AUTHORITY_REQUIRED	Public	4,030	2,024	AUGUST
13723G	infliximab	Inflectra	Powder for I.V. infusion 100 mg	rheumatoid arthritis	Initial treatment - Initial 1 (new patient)	null	true	AUTHORITY_REQUIRED	Public	4,030	2,024	AUGUST
13723G	infliximab	Renflexis	Powder for I.V. infusion 100 mg	rheumatoid arthritis	Initial treatment - Initial 1 (new patient)	null	true	AUTHORITY_REQUIRED	Public	4,030	2,024	AUGUST
13305G	tocilizumab	Actemra	Concentrate for injection 200 mg in 10 mL	juvenile idiopathic arthritis	Continuing treatment	14164	true	STREAMLINED	Public	4,030	2,024	AUGUST
13735X	certolizumab pegol	Cimzia	Injection 200 mg in 1 mL single use pre-filled syringe	rheumatoid arthritis	Subsequent continuing treatment	14499	true	STREAMLINED	Any	4,030	2,024	AUGUST
12775J	tocilizumab	Actemra	Concentrate for injection 80 mg in 4 mL	rheumatoid arthritis	Initial treatment - Initial 4 (Temporary listing - change of treatment from another biological medicine to tocilizumab after resolution of the critical shortage of tocilizumab)	null	true	AUTHORITY_REQUIRED	Public	4,030	2,024	AUGUST
13704G	adalimumab	Adalicip	Injection 40 mg in 0.4 mL pre-filled syringe	rheumatoid arthritis	Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months)	null	true	AUTHORITY_REQUIRED	Any	4,030	2,024	AUGUST

13308K

etanercept

Enbrel

Injections 50 mg in 1 mL single use pre-filled syringes, 4

juvenile idiopathic arthritis

Continuing treatment

14154

true

STREAMLINED

Public

4,030

2,024

AUGUST

13757C

tofacitinib

Xeljanz

Tablet 5 mg

juvenile idiopathic arthritis

Transitioning from non-PBS to PBS-subsidised supply - Grandfather arrangements

null

true

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST

9034L

adalimumab

Abrilada

Injection 40 mg in 0.8 mL pre-filled syringe

psoriatic arthritis

Continuing treatment - balance of supply

null

true

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST

9034L

adalimumab

Idacio

Injection 40 mg in 0.8 mL pre-filled syringe

psoriatic arthritis

Continuing treatment - balance of supply

null

true

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST

9034L

adalimumab

Hadlima

Injection 40 mg in 0.8 mL pre-filled syringe

psoriatic arthritis

Continuing treatment - balance of supply

null

true

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST

9034L

adalimumab

Hyrimoz

Injection 40 mg in 0.8 mL pre-filled syringe

psoriatic arthritis

Continuing treatment - balance of supply

null

true

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST

9034L

adalimumab

Amgevita

Injection 40 mg in 0.8 mL pre-filled syringe

psoriatic arthritis

Continuing treatment - balance of supply

null

true

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST

9034L

adalimumab

Abrilada

Injection 40 mg in 0.8 mL pre-filled syringe

psoriatic arthritis

First continuing treatment

null

false

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST

9034L

adalimumab

Idacio

Injection 40 mg in 0.8 mL pre-filled syringe

psoriatic arthritis

First continuing treatment

null

false

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST

9034L

adalimumab

Hadlima

Injection 40 mg in 0.8 mL pre-filled syringe

psoriatic arthritis

First continuing treatment

null

false

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST

9034L

adalimumab

Hyrimoz

Injection 40 mg in 0.8 mL pre-filled syringe

psoriatic arthritis

First continuing treatment

null

false

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST

9034L

adalimumab

Amgevita

Injection 40 mg in 0.8 mL pre-filled syringe

psoriatic arthritis

First continuing treatment

null

false

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST

9034L

adalimumab

Abrilada

Injection 40 mg in 0.8 mL pre-filled syringe

psoriatic arthritis

Subsequent continuing treatment

null

false

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST

9034L

adalimumab

Idacio

Injection 40 mg in 0.8 mL pre-filled syringe

psoriatic arthritis

Subsequent continuing treatment

null

false

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST

9034L

adalimumab

Hadlima

Injection 40 mg in 0.8 mL pre-filled syringe

psoriatic arthritis

Subsequent continuing treatment

null

false

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST

9034L

adalimumab

Hyrimoz

Injection 40 mg in 0.8 mL pre-filled syringe

psoriatic arthritis

Subsequent continuing treatment

null

false

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST

9034L

adalimumab

Amgevita

Injection 40 mg in 0.8 mL pre-filled syringe

psoriatic arthritis

Subsequent continuing treatment

null

false

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST

11516D

golimumab

Simponi

Injection 50 mg in 0.5 mL single use pre-filled syringe

non-radiographic axial spondyloarthritis

Continuing treatment - balance of supply

null

true

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST

11516D

golimumab

Simponi

Injection 50 mg in 0.5 mL single use pre-filled syringe

non-radiographic axial spondyloarthritis

Continuing treatment

null

true

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST

10767Q

ustekinumab

Stelara

Injection 45 mg in 0.5 mL

psoriatic arthritis

Continuing treatment - balance of supply

null

true

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST

10767Q

ustekinumab

Stelara

Injection 45 mg in 0.5 mL

psoriatic arthritis

Continuing treatment

null

false

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST

13720D

tocilizumab

Actemra ACTPen

Injection 162 mg in 0.9 mL single use pre-filled pen

rheumatoid arthritis

Subsequent continuing treatment

14499

true

STREAMLINED

Any

4,030

2,024

AUGUST

13065P

infliximab

Remsima SC

Solution for injection 120 mg in 1 mL pre-filled syringe

ankylosing spondylitis

Balance of supply (including switching formulation) where the full duration of treatment available under a particular treatment phase was not requested in the preceding prescription

null

true

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST

12217B

ixekizumab

Taltz

Injection 80 mg in 1 mL single dose pre-filled pen

ankylosing spondylitis

Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)

null

false

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST

12217B

ixekizumab

Taltz

Injection 80 mg in 1 mL single dose pre-filled pen

ankylosing spondylitis

Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years)

null

false

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST

12217B

ixekizumab

Taltz

Injection 80 mg in 1 mL single dose pre-filled pen

ankylosing spondylitis

Initial treatment - Initial 1 (new patient), Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply

null

true

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST

12217B

ixekizumab

Taltz

Injection 80 mg in 1 mL single dose pre-filled pen

ankylosing spondylitis

Initial treatment - Initial 1 (new patient)

null

false

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST

3428K

golimumab

Simponi

Injection 50 mg in 0.5 mL single use pre-filled syringe

rheumatoid arthritis

First continuing treatment

null

false

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST

3428K

golimumab

Simponi

Injection 50 mg in 0.5 mL single use pre-filled syringe

rheumatoid arthritis

First continuing treatment - balance of supply

null

true

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST

11375Q

golimumab

Simponi

Injection 50 mg in 0.5 mL single use pre-filled pen

rheumatoid arthritis

First continuing treatment - balance of supply

null

true

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST

11375Q

golimumab

Simponi

Injection 50 mg in 0.5 mL single use pre-filled pen

rheumatoid arthritis

First continuing treatment

null

false

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST

3449M

etanercept

Enbrel

Injections 50 mg in 1 mL single use pre-filled syringes, 4

juvenile idiopathic arthritis

Continuing Treatment - balance of supply

null

true

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST

3449M

etanercept

Enbrel

Injections 50 mg in 1 mL single use pre-filled syringes, 4

juvenile idiopathic arthritis

Continuing treatment

null

false

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST

13223Y

adalimumab

Yuflyma

Injection 40 mg in 0.4 mL pre-filled pen

juvenile idiopathic arthritis

Subsequent continuing treatment

11604

true

STREAMLINED

Any

4,030

2,024

AUGUST

13223Y

adalimumab

Adalicip

Injection 40 mg in 0.4 mL pre-filled pen

juvenile idiopathic arthritis

Subsequent continuing treatment

11604

true

STREAMLINED

Any

4,030

2,024

AUGUST

11498E

infliximab

Inflectra

Powder for I.V. infusion 100 mg

psoriatic arthritis

Subsequent continuing treatment

null

false

AUTHORITY_REQUIRED

Private

4,030

2,024

AUGUST

11498E

infliximab

Renflexis

Powder for I.V. infusion 100 mg

psoriatic arthritis

Subsequent continuing treatment

null

false

AUTHORITY_REQUIRED

Private

4,030

2,024

AUGUST

11498E

infliximab

Remicade

Powder for I.V. infusion 100 mg

psoriatic arthritis

Subsequent continuing treatment

null

false

AUTHORITY_REQUIRED

Private

4,030

2,024

AUGUST

11197H

etanercept

Enbrel

Injection set containing 4 vials powder for injection 25 mg and 4 pre-filled syringes solvent 1 mL

rheumatoid arthritis

Subsequent continuing treatment

14499

true

STREAMLINED

Any

4,030

2,024

AUGUST

6448J

infliximab

Remicade

Powder for I.V. infusion 100 mg

ankylosing spondylitis

Initial treatment - Initial 1 (new patient), Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply

null

true

AUTHORITY_REQUIRED

Private

4,030

2,024

AUGUST

6448J

infliximab

Inflectra

Powder for I.V. infusion 100 mg

ankylosing spondylitis

Initial treatment - Initial 1 (new patient), Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply

null

true

AUTHORITY_REQUIRED

Private

4,030

2,024

AUGUST

6448J

infliximab

Renflexis

Powder for I.V. infusion 100 mg

ankylosing spondylitis

Initial treatment - Initial 1 (new patient), Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply

null

true

AUTHORITY_REQUIRED

Private

4,030

2,024

AUGUST

6448J

infliximab

Remicade

Powder for I.V. infusion 100 mg

ankylosing spondylitis

Initial treatment - Initial 1 (new patient)

null

false

AUTHORITY_REQUIRED

Private

4,030

2,024

AUGUST

6448J

infliximab

Inflectra

Powder for I.V. infusion 100 mg

ankylosing spondylitis

Initial treatment - Initial 1 (new patient)

null

false

AUTHORITY_REQUIRED

Private

4,030

2,024

AUGUST

6448J

infliximab

Renflexis

Powder for I.V. infusion 100 mg

ankylosing spondylitis

Initial treatment - Initial 1 (new patient)

null

false

AUTHORITY_REQUIRED

Private

4,030

2,024

AUGUST

6448J

infliximab

Remicade

Powder for I.V. infusion 100 mg

ankylosing spondylitis

Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)

null

false

AUTHORITY_REQUIRED

Private

4,030

2,024

AUGUST

6448J

infliximab

Inflectra

Powder for I.V. infusion 100 mg

ankylosing spondylitis

Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)

null

false

AUTHORITY_REQUIRED

Private

4,030

2,024

AUGUST

6448J

infliximab

Renflexis

Powder for I.V. infusion 100 mg

ankylosing spondylitis

Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)

null

false

AUTHORITY_REQUIRED

Private

4,030

2,024

AUGUST

6448J

infliximab

Remicade

Powder for I.V. infusion 100 mg

ankylosing spondylitis

Continuing treatment - balance of supply

null

true

AUTHORITY_REQUIRED

Private

4,030

2,024

AUGUST

6448J

infliximab

Inflectra

Powder for I.V. infusion 100 mg

ankylosing spondylitis

Continuing treatment - balance of supply

null

true

AUTHORITY_REQUIRED

Private

4,030

2,024

AUGUST

6448J

infliximab

Renflexis

Powder for I.V. infusion 100 mg

ankylosing spondylitis

Continuing treatment - balance of supply

null

true

AUTHORITY_REQUIRED

Private

4,030

2,024

AUGUST

6448J

infliximab

Remicade

Powder for I.V. infusion 100 mg

ankylosing spondylitis

Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years)

null

false

AUTHORITY_REQUIRED

Private

4,030

2,024

AUGUST

6448J

infliximab

Inflectra

Powder for I.V. infusion 100 mg

ankylosing spondylitis

Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years)

null

false

AUTHORITY_REQUIRED

Private

4,030

2,024

AUGUST

6448J

infliximab

Renflexis

Powder for I.V. infusion 100 mg

ankylosing spondylitis

Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years)

null

false

AUTHORITY_REQUIRED

Private

4,030

2,024

AUGUST

6448J

infliximab

Remicade

Powder for I.V. infusion 100 mg

ankylosing spondylitis

First continuing treatment

null

false

AUTHORITY_REQUIRED

Private

4,030

2,024

AUGUST

6448J

infliximab

Inflectra

Powder for I.V. infusion 100 mg

ankylosing spondylitis

First continuing treatment

null

false

AUTHORITY_REQUIRED

Private

4,030

2,024

AUGUST

6448J

infliximab

Renflexis

Powder for I.V. infusion 100 mg

ankylosing spondylitis

First continuing treatment

null

false

AUTHORITY_REQUIRED

Private

4,030

2,024

AUGUST

13228F

adalimumab

Humira

Injection 40 mg in 0.4 mL pre-filled syringe

juvenile idiopathic arthritis

Continuing treatment

14136

true

STREAMLINED

Public

4,030

2,024

AUGUST

13228F

adalimumab

Yuflyma

Injection 40 mg in 0.4 mL pre-filled syringe

juvenile idiopathic arthritis

Continuing treatment

14136

true

STREAMLINED

Public

4,030

2,024

AUGUST

13228F

adalimumab

Adalicip

Injection 40 mg in 0.4 mL pre-filled syringe

juvenile idiopathic arthritis

Continuing treatment

14136

true

STREAMLINED

Public

4,030

2,024

AUGUST

13315T

tocilizumab

Actemra

Concentrate for injection 80 mg in 4 mL

juvenile idiopathic arthritis

Continuing treatment

14179

true

STREAMLINED

Private

4,030

2,024

AUGUST

13047Q

infliximab

Remsima SC

Solution for injection 120 mg in 1 mL pre-filled syringe

psoriatic arthritis

Continuing treatment with subcutaneous form or switching from intravenous form to subcutaneous form

null

true

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST

6397Q

infliximab

Remicade

Powder for I.V. infusion 100 mg

rheumatoid arthritis

Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)

null

false

AUTHORITY_REQUIRED

Private

4,030

2,024

AUGUST

6397Q

infliximab

Renflexis

Powder for I.V. infusion 100 mg

rheumatoid arthritis

Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)

null

false

AUTHORITY_REQUIRED

Private

4,030

2,024

AUGUST

6397Q

infliximab

Inflectra

Powder for I.V. infusion 100 mg

rheumatoid arthritis

Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)

null

false

AUTHORITY_REQUIRED

Private

4,030

2,024

AUGUST

6397Q

infliximab

Remicade

Powder for I.V. infusion 100 mg

rheumatoid arthritis

Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply

null

true

AUTHORITY_REQUIRED

Private

4,030

2,024

AUGUST

6397Q

infliximab

Renflexis

Powder for I.V. infusion 100 mg

rheumatoid arthritis

Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply

null

true

AUTHORITY_REQUIRED

Private

4,030

2,024

AUGUST

6397Q

infliximab

Inflectra

Powder for I.V. infusion 100 mg

rheumatoid arthritis

Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply

null

true

AUTHORITY_REQUIRED

Private

4,030

2,024

AUGUST

6397Q

infliximab

Remicade

Powder for I.V. infusion 100 mg

rheumatoid arthritis

First continuing treatment

null

false

AUTHORITY_REQUIRED

Private

4,030

2,024

AUGUST

6397Q

infliximab

Renflexis

Powder for I.V. infusion 100 mg

rheumatoid arthritis

First continuing treatment

null

false

AUTHORITY_REQUIRED

Private

4,030

2,024

AUGUST

6397Q

infliximab

Inflectra

Powder for I.V. infusion 100 mg

rheumatoid arthritis

First continuing treatment

null

false

AUTHORITY_REQUIRED

Private

4,030

2,024

AUGUST

6397Q

infliximab

Remicade

Powder for I.V. infusion 100 mg

rheumatoid arthritis

Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months)

null

false

AUTHORITY_REQUIRED

Private

4,030

2,024

AUGUST

6397Q

infliximab

Renflexis

Powder for I.V. infusion 100 mg

rheumatoid arthritis

Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months)

null

false

AUTHORITY_REQUIRED

Private

4,030

2,024

AUGUST

6397Q

infliximab

Inflectra

Powder for I.V. infusion 100 mg

rheumatoid arthritis

Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months)

null

false

AUTHORITY_REQUIRED

Private

4,030

2,024

AUGUST

6397Q

infliximab

Remicade

Powder for I.V. infusion 100 mg

rheumatoid arthritis

First continuing treatment - balance of supply

null

true

AUTHORITY_REQUIRED

Private

4,030

2,024

AUGUST

6397Q

infliximab

Renflexis

Powder for I.V. infusion 100 mg

rheumatoid arthritis

First continuing treatment - balance of supply

null

true

AUTHORITY_REQUIRED

Private

4,030

2,024

AUGUST

6397Q

infliximab

Inflectra

Powder for I.V. infusion 100 mg

rheumatoid arthritis

First continuing treatment - balance of supply

null

true

AUTHORITY_REQUIRED

Private

4,030

2,024

AUGUST

6397Q

infliximab

Remicade

Powder for I.V. infusion 100 mg

rheumatoid arthritis

Initial treatment - Initial 1 (new patient)

null

false

AUTHORITY_REQUIRED

Private

4,030

2,024

AUGUST

6397Q

infliximab

Renflexis

Powder for I.V. infusion 100 mg

rheumatoid arthritis

Initial treatment - Initial 1 (new patient)

null

false

AUTHORITY_REQUIRED

Private

4,030

2,024

AUGUST

6397Q

infliximab

Inflectra

Powder for I.V. infusion 100 mg

rheumatoid arthritis

Initial treatment - Initial 1 (new patient)

null

false

AUTHORITY_REQUIRED

Private

4,030

2,024

AUGUST

11675L

tofacitinib

Xeljanz

Tablet 5 mg

psoriatic arthritis

Continuing treatment

null

false

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST

11675L

tofacitinib

Xeljanz

Tablet 5 mg

psoriatic arthritis

Continuing treatment - balance of supply

null

true

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST

12094M

tocilizumab

Actemra ACTPen

Injection 162 mg in 0.9 mL single use pre-filled pen

juvenile idiopathic arthritis

Balance of supply for Initial treatment - Initial 1 (new patient) or Initial 2 (retrial or recommencement of treatment after a break of less than 12 months) or Initial 3 (recommencement of treatment after a break of more than 12 months) - in a patient of any weight being administered a subcutaneous form of this biological medicine

null

true

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST

12355G

adalimumab

Abrilada

Injection 40 mg in 0.8 mL pre-filled pen

juvenile idiopathic arthritis

Continuing treatment

14136

true

STREAMLINED

Public

4,030

2,024

AUGUST

12355G

adalimumab

Amgevita

Injection 40 mg in 0.8 mL pre-filled pen

juvenile idiopathic arthritis

Continuing treatment

14136

true

STREAMLINED

Public

4,030

2,024

AUGUST

12355G

adalimumab

Hyrimoz

Injection 40 mg in 0.8 mL pre-filled pen

juvenile idiopathic arthritis

Continuing treatment

14136

true

STREAMLINED

Public

4,030

2,024

AUGUST

12355G

adalimumab

Hadlima

Injection 40 mg in 0.8 mL pre-filled pen

juvenile idiopathic arthritis

Continuing treatment

14136

true

STREAMLINED

Public

4,030

2,024

AUGUST

12355G

adalimumab

Idacio

Injection 40 mg in 0.8 mL pre-filled pen

juvenile idiopathic arthritis

Continuing treatment

14136

true

STREAMLINED

Public

4,030

2,024

AUGUST

13723G

infliximab

Inflectra

Powder for I.V. infusion 100 mg

rheumatoid arthritis

Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)

null

true

AUTHORITY_REQUIRED

Public

4,030

2,024

AUGUST

13723G

infliximab

Renflexis

Powder for I.V. infusion 100 mg

rheumatoid arthritis

Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)

null

true

AUTHORITY_REQUIRED

Public

4,030

2,024

AUGUST

13723G

infliximab

Inflectra

Powder for I.V. infusion 100 mg

rheumatoid arthritis

Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply

null

true

AUTHORITY_REQUIRED

Public

4,030

2,024

AUGUST

13723G

infliximab

Renflexis

Powder for I.V. infusion 100 mg

rheumatoid arthritis

Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply

null

true

AUTHORITY_REQUIRED

Public

4,030

2,024

AUGUST

13723G

infliximab

Inflectra

Powder for I.V. infusion 100 mg

rheumatoid arthritis

Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months)

null

true

AUTHORITY_REQUIRED

Public

4,030

2,024

AUGUST

13723G

infliximab

Renflexis

Powder for I.V. infusion 100 mg

rheumatoid arthritis

Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months)

null

true

AUTHORITY_REQUIRED

Public

4,030

2,024

AUGUST

13723G

infliximab

Inflectra

Powder for I.V. infusion 100 mg

rheumatoid arthritis

Initial treatment - Initial 1 (new patient)

null

true

AUTHORITY_REQUIRED

Public

4,030

2,024

AUGUST

13723G

infliximab

Renflexis

Powder for I.V. infusion 100 mg

rheumatoid arthritis

Initial treatment - Initial 1 (new patient)

null

true

AUTHORITY_REQUIRED

Public

4,030

2,024

AUGUST

13305G

tocilizumab

Actemra

Concentrate for injection 200 mg in 10 mL

juvenile idiopathic arthritis

Continuing treatment

14164

true

STREAMLINED

Public

4,030

2,024

AUGUST

13735X

certolizumab pegol

Cimzia

Injection 200 mg in 1 mL single use pre-filled syringe

rheumatoid arthritis

Subsequent continuing treatment

14499

true

STREAMLINED

Any

4,030

2,024

AUGUST

12775J

tocilizumab

Actemra

Concentrate for injection 80 mg in 4 mL

rheumatoid arthritis

Initial treatment - Initial 4 (Temporary listing - change of treatment from another biological medicine to tocilizumab after resolution of the critical shortage of tocilizumab)

null

true

AUTHORITY_REQUIRED

Public

4,030

2,024

AUGUST

13704G

adalimumab

Adalicip

Injection 40 mg in 0.4 mL pre-filled syringe

rheumatoid arthritis

Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months)

null

true

AUTHORITY_REQUIRED

Any

4,030

2,024

AUGUST